Skip to main content
. 2014 Jan 28;9(1):e87475. doi: 10.1371/journal.pone.0087475

Figure 3. The in vitro effects of DAC and Ara-C in combination in primary paediatric AML.

Figure 3

A) The percentage of viable cells following treatment with each drug regimen compared to PBS controls in 5 primary AML patient cultures (* P<0.01). All experiments were performed in triplicate. B) The percentage of cells in each phase of cell cycle following treatment with each drug regimen, for a representative primary AML sample (AML-7). All experiments were performed in duplicate.